Atlas, Bain, and RTW Investments have co-led a $400 million Series A financing for the new obesity startup Kailera Therapeutics. The company, led by CEO Ron Renaud, has a clinically validated portfolio of next-generation therapies for obesity. Metsera, another biotech company focusing on obesity treatments, has already struck a commercial manufacturing deal with Amneal Pharmaceuticals. Senator Bill Cassidy has urged the FDA to clarify patent listing rules for drug-and-device combination products. Johnson & Johnson has decided not to alter payment methods for hospitals in the 340B program. Roche defends its obesity pipeline amid skepticism.
Source link
Atlas, Bain, J&J, Roche, Bristol news
